Laurus Labs has allotted 31,683 equity shares under ESOP on 02 December 2025. The total paid up capital of the Company after the above allotment stands at Rs.1,07,97,13,164/-.Powered by Capital Market - Live News

Net profit of Laurus Labs rose 882.71% to Rs 194.97 crore in the quarter ended September 2025 as against Rs 19.84 crore during the previous quarter ended September 2024. Sales rose 35.12% to Rs 1653.47 crore in the quarter ended September 2025 as against Rs 1223.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1653.471223.70 35 OPM %24.3914.57 - PBDT390.22130.32 199 PBT269.7322.81 1083 NP194.9719.84 883 Powered by Capital Market - Live News

Laurus Labs announced that the Board of Directors of the Company at its meeting held on 23 October 2025, inter alia, have recommended the interim dividend of Rs 0.8 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Laurus Labs will hold a meeting of the Board of Directors of the Company on 23 October 2025.Powered by Capital Market - Live News

Net profit of Laurus Labs rose 1203.12% to Rs 163.02 crore in the quarter ended June 2025 as against Rs 12.51 crore during the previous quarter ended June 2024. Sales rose 31.35% to Rs 1569.57 crore in the quarter ended June 2025 as against Rs 1194.91 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1569.571194.91 31 OPM %24.3514.33 - PBDT341.06124.52 174 PBT224.2218.46 1115 NP163.0212.51 1203 Powered by Capital Market - Live News